ReP USP - Resultado da busca

Artigo de periodico
AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility (2016)
Silva, Thaiomara Alves; Smuczek, Basílio; Valadão, Iuri Cordeiro; Dzik, Luciana Machado; Iglesia, Rebeca Piatniczka; Cruz, Mário Costa; Pereira, André Zelanis Palitot; Siqueria, Adriane Sousa de; Serrano, Solange Maria de Toledo; Goldberg, Gary S; Jaeger, Ruy Gastaldoni ; Freitas, Vanessa Morais
Source: OncoTarget. Unidade: ICB
Subjects: CARCINOMA, TUMOR CARCINOIDE, FIBROBLASTOS, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Thaiomara Alves et al. AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility. OncoTarget, v. 7, n. 31, p. 49998-50016, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.10307. Acesso em: 15 nov. 2024.
APA
Silva, T. A., Smuczek, B., Valadão, I. C., Dzik, L. M., Iglesia, R. P., Cruz, M. C., et al. (2016). AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility. OncoTarget, 7( 31), 49998-50016. doi:10.18632/oncotarget.10307
NLM
Silva TA, Smuczek B, Valadão IC, Dzik LM, Iglesia RP, Cruz MC, Pereira AZP, Siqueria AS de, Serrano SM de T, Goldberg GS, Jaeger RG, Freitas VM. AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility [Internet]. OncoTarget. 2016 ; 7( 31): 49998-50016.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.10307
Vancouver
Silva TA, Smuczek B, Valadão IC, Dzik LM, Iglesia RP, Cruz MC, Pereira AZP, Siqueria AS de, Serrano SM de T, Goldberg GS, Jaeger RG, Freitas VM. AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility [Internet]. OncoTarget. 2016 ; 7( 31): 49998-50016.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.10307
Artigo de periodico
Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model (2016)
Souza, Jean Gabriel de; Morais, Katia L. P.; Anglés-Cano, Eduardo; Boufleur, Pamela; Mello, Evandro Sobroza de; Maria, Durvanei Augusto; Origassa, Clarice Silvia Taemi; Zampolli, Hamilton de Campos; Câmara, Niels Olsen Saraiva ; Berra, Carolina Maria; Bosch, Rosemary Viola Bosch; Chudzinski-Tavassi, Ana Marisa
Source: OncoTarget. Unidade: ICB
Subjects: NEOPLASIAS RENAIS, NEOPLASIAS PULMONARES, ADENOCARCINOMA, AMBLYOMMA CAJENNENSE, CARRAPATOS, GLÂNDULAS SALIVARES, MEDICAMENTO, METÁSTASE NEOPLÁSICA, APOPTOSE, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Jean Gabriel de et al. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model. OncoTarget, v. 7, n. 38, p. 62255-62266, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.11555. Acesso em: 15 nov. 2024.
APA
Souza, J. G. de, Morais, K. L. P., Anglés-Cano, E., Boufleur, P., Mello, E. S. de, Maria, D. A., et al. (2016). Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model. OncoTarget, 7( 38), 62255-62266. doi:10.18632/oncotarget.11555
NLM
Souza JG de, Morais KLP, Anglés-Cano E, Boufleur P, Mello ES de, Maria DA, Origassa CST, Zampolli H de C, Câmara NOS, Berra CM, Bosch RVB, Chudzinski-Tavassi AM. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model [Internet]. OncoTarget. 2016 ; 7( 38): 62255-62266.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.11555
Vancouver
Souza JG de, Morais KLP, Anglés-Cano E, Boufleur P, Mello ES de, Maria DA, Origassa CST, Zampolli H de C, Câmara NOS, Berra CM, Bosch RVB, Chudzinski-Tavassi AM. Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model [Internet]. OncoTarget. 2016 ; 7( 38): 62255-62266.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.11555
Artigo de periodico
Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression (2016)
Cortez, Beatriz Araujo; Teixeira, Paula Rezende; Redick, Sambra; Doxsey, Stephen; Santelli, Glaucia Maria Machado
Source: OncoTarget. Unidade: ICB
Subjects: ASBESTO, MITOSE, NEOPLASIAS PULMONARES, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORTEZ, Beatriz Araujo et al. Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression. OncoTarget, v. 7, n. 8, p. 8979-8992, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.6924. Acesso em: 15 nov. 2024.
APA
Cortez, B. A., Teixeira, P. R., Redick, S., Doxsey, S., & Santelli, G. M. M. (2016). Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression. OncoTarget, 7( 8), 8979-8992. doi:10.18632/oncotarget.6924
NLM
Cortez BA, Teixeira PR, Redick S, Doxsey S, Santelli GMM. Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression [Internet]. OncoTarget. 2016 ; 7( 8): 8979-8992.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.6924
Vancouver
Cortez BA, Teixeira PR, Redick S, Doxsey S, Santelli GMM. Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression [Internet]. OncoTarget. 2016 ; 7( 8): 8979-8992.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.6924
Artigo de periodico
Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2 (2016)
Siqueira, Adriane Sousa de; Pinto, Monique Rodrigues Pereira; Cruz, Mário Costa; Smuczek, Basilio; Cruz, Karen Steponavicius Piedade; Barbuto, José Alexandre Marzagão ; Hoshino, Daisuke; Weaver, Alissa M; Freitas, Vanessa Morais ; Jaeger, Ruy Gastaldoni
Source: OncoTarget. Unidade: ICB
Subjects: PEPTÍDEOS, INTEGRINAS, CARCINOMA DE CÉLULAS ESCAMOSAS, FIBROSSARCOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIQUEIRA, Adriane Sousa de et al. Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2. OncoTarget, v. 7, n. 30, p. 47904-4717, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.10062. Acesso em: 15 nov. 2024.
APA
Siqueira, A. S. de, Pinto, M. R. P., Cruz, M. C., Smuczek, B., Cruz, K. S. P., Barbuto, J. A. M., et al. (2016). Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2. OncoTarget, 7( 30), 47904-4717. doi:10.18632/oncotarget.10062
NLM
Siqueira AS de, Pinto MRP, Cruz MC, Smuczek B, Cruz KSP, Barbuto JAM, Hoshino D, Weaver AM, Freitas VM, Jaeger RG. Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2 [Internet]. OncoTarget. 2016 ; 7( 30): 47904-4717.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.10062
Vancouver
Siqueira AS de, Pinto MRP, Cruz MC, Smuczek B, Cruz KSP, Barbuto JAM, Hoshino D, Weaver AM, Freitas VM, Jaeger RG. Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2 [Internet]. OncoTarget. 2016 ; 7( 30): 47904-4717.[citado 2024 nov. 15 ] Available from: https://doi.org/10.18632/oncotarget.10062

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation